D. Fancelli

发表

FCE 27677: a novel inhibitor of acyl-CoA: cholesterol acyltransferase with potent oral hypolipidemic activity.

G. Ghiselli, D. Severino, A. Chiari, 1995, Pharmacological research.

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer

Paola Storici, Cristina Alli, Maurizio Rocchetti, 2007, Molecular Cancer Therapeutics.

Bicyclopyrazoles actifs comme inhibiteurs de la kinase

A. Borgia, T. Bandiera, P. Pevarello, 2007 .

High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons

C. Mercurio, M. Varasi, M. Gabriele, 2020, Molecular Autism.

PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity

D. Ballinari, V. Croci, P. Cappella, 2006, Clinical Cancer Research.

Cellular Neuroscience

L. Martin, S. Plyte, Qing Chang, 2022 .

Targeted inhibition of the gatekeeper mutant T315I of Bcr-Abl by an Aurora kinase inhibitor

M. Modugno, A. Isacchi, E. Casale, 2007 .

Inhibitors of Aurora kinases for the treatment of cancer

J. Moll, D. Fancelli, 2005 .

Compounds and methods for inhibiting mitotic progression

D. Fancelli, 2006 .

3-Amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: a new class of CDK2 inhibitors.

J. Bischoff, C. Mercurio, A. Vulpetti, 2006, Bioorganic & medicinal chemistry letters.

Solid phase synthesis of 2-substituted benzofurans via the palladium-catalysed heteroannulation of acetylenes

A. Bedeschi, D. Severino, D. Fancelli, 1997 .

1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.

Paola Storici, Maurizio Rocchetti, Enrico Pesenti, 2006, Journal of medicinal chemistry.

Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition.

A. Vulpetti, F. Roletto, P. Cappella, 2005, Journal of medicinal chemistry.

Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.

V. Croci, D. Volpi, F. Roletto, 2010, Bioorganic & medicinal chemistry.

Sintering Fundamentals of Magnesium Powders

G. Kipouros, P. Burke, D. Fancelli, 2009 .

Serotoninergic 5-HT3 and 5-HT4 receptor activities of dihydrobenzofuran carboxylic acid derivatives

C. Caccia, M. Varasi, R. Mcarthur, 1996 .

Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo.

S. Minucci, P. Pelicci, R. Amici, 2014, Journal of medicinal chemistry.

6‐Substituted Pyrrolo[3,4‐c]pyrazoles: An Improved Class of CDK2 Inhibitors

C. Mercurio, A. Vulpetti, D. Ballinari, 2007, ChemMedChem.

Crystal structure of the T315I Abl mutant in complex with the aurora kinases inhibitor PHA-739358.

Antonella Isacchi, Riccardo Colombo, Michele Modugno, 2007, Cancer research.

An update on therapeutic opportunities offered by cancer glycolytic metabolism.

Carlotta Granchi, Filippo Minutolo, F. Minutolo, 2014, Bioorganic & medicinal chemistry letters.

Quantitative Chemical Proteomics Identifies Novel Targets of the Anti-cancer Multi-kinase Inhibitor E-3810

Tiziana Bonaldi, S. Minucci, T. Bonaldi, 2014, Molecular & Cellular Proteomics.

Imidazolylbenzopyrane derivatives: a new class of acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors.

P. Cozzi, G. Ghiselli, D. Severino, 1994, Journal of enzyme inhibition.

Manganese(III) acetate induced cyclization of α-arylalkyl and α-(aryloxy)alkyl β-dicarbonyl derivatives

L. Pesce, A. Citterio, D. Fancelli, 1989 .

Synthesis and pharmacological profile of FCE 28654: A water-soluble and injectable ACAT inhibitor

G. Ghiselli, D. Severino, A. Chiari, 1995 .

GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis

L. Martin, S. Plyte, Qing Chang, 2014, Front. Cell. Neurosci..

Novel selective inhibitors of macropinocytosis-dependent growth in pancreatic ductal carcinoma

C. Mercurio, E. Frittoli, S. Dey, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.